Drug Interactions, Allergy and Medication Teaching

Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions

Pharmacotherapy requires close attention to how concurrent medications interact within the body. Pharmacokinetic interactions occur when one agent alters the absorption, distribution, metabolism, or excretion of another. For instance, St. John's wort acts as a potent inducer of drug-metabolizing enzymes and transporters. By inducing drug-metabolizing enzymes and transporters, including P-glycoprotein, St. John's wort can reduce warfarin and digoxin exposure and decrease the effectiveness of oral contraceptives. In contrast, pharmacodynamic interactions occur when drugs produce additive, synergistic, or antagonistic biological effects when taken together.

Renal mechanisms frequently mediate severe drug-drug interactions. Nonsteroidal anti-inflammatory drugs decrease renal blood flow, an action that blunts the therapeutic efficacy of concurrent antihypertensives and diuretics. Furthermore, this decreased renal perfusion significantly reduces the renal clearance of lithium, putting the client at grave risk for lithium toxicity. Combining drugs that have overlapping organ toxicities can compound client injury. For example, administering loop diuretics together with aminoglycosides significantly escalates the risks of both ototoxicity and nephrotoxicity.

Other drug pairings produce dangerous metabolic or biochemical disturbances. Combining an angiotensin-converting enzyme inhibitor with a potassium-sparing diuretic creates a pronounced additive effect that heightens the risk of severe hyperkalemia. Combining St. John's wort with selective serotonin reuptake inhibitors significantly increases the risk of serotonin syndrome. When clients receive narrow-therapeutic-index medications, specialized monitoring is non-negotiable. These fragile therapeutic regimens mandate drug-specific monitoring, which may include obtaining serum drug levels or performing other designated laboratory tests to verify safety.